Nagy Habib

Nagy Habib (born 5 August 1952) is a Professor of Surgery based in London.

Professor of Hepato-biliary Surgery Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Imperial College London

Born and educated in Cairo, Egypt, Habib completed his medical training in the UK. Habib specialised in liver surgery and was appointed Consultant at Hammersmith Hospital, in 1989. Alongside surgery at Hammersmith Hospital, Imperial College Healthcare NHS Trust, Habib has had ongoing research in stem cells and gene therapy at Imperial College. Habib was appointed Professor of Hepatobiliary Surgery in 2003, and Chair of Surgery in 2007. In 2007 Habib was appointed Pro-Rector of Commercial Affairs.

Professor Habib has published over 200 papers in peer reviewed journals and sits on the editorial review panels of the European Journal of Cancer and the Annals of the Royal College of Surgeons of England. Habib is one of the proponents of adult stem cell research, in the treatment of advanced cases of cancer [1].

Professor Habib revolutionised liver surgery by adopting the use of radio frequency in liver resections, allowing tumours to be removed with minimal loss of blood. The technique has been published in the Annals of Surgery and elsewhere and later commercialised by Professor Habib through Emcision [2], a private company he founded. The Habib 4X [3] open and laparoscopic electrosurgical devices are distributed by AngioDynamics, Inc. The devices have been adopted for distal pancreatectomy, partial nephrectomy, and myeomectomy procedures.